Related Experiment Video
Updated: Dec 12, 2025

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
Subcortical T1-Rho MRI Abnormalities in Juvenile-Onset Huntington's Disease
Alexander V Tereshchenko1, Jordan L Schultz1,2,3, Ansley J Kunnath4
1Department of Psychiatry, Carver College of Medicine at the University of Iowa, Iowa City, IA 52242, USA.
Insights
Juvenile-onset Huntington's disease (JOHD) shows increased subcortical metabolic abnormalities. T1-Rho MRI revealed higher relaxation times in key brain regions, correlating with disease severity and motor deficits in JOHD patients.
Area of Science:
- Neuroimaging
- Neurodegenerative Diseases
- Genetics
Background:
- Huntington's disease (HD) is a fatal neurodegenerative disorder caused by CAG repeat expansion in the huntingtin gene.
- Juvenile-onset Huntington's disease (JOHD) accounts for 5% of cases, presenting before age 21.
- Subcortical metabolic changes are implicated in HD pathogenesis.
Purpose of the Study:
- To measure subcortical metabolic abnormalities in JOHD participants using T1-Rho MRI.
- To investigate the relationship between metabolic changes, brain volume, and clinical scores in JOHD.
Main Methods:
- T1-Rho (T1ρ) MRI was employed to compare brain regions between 13 JOHD participants and 39 controls.
- Region-of-interest analyses quantified differences in T1ρ relaxation times.
- Correlation analyses assessed relationships between T1ρ, brain volume, and Universal Huntington's Disease Rating Scale (UHDRS) scores.
Main Results:
- JOHD participants exhibited significantly increased mean T1ρ relaxation times in the caudate, putamen, globus pallidus, and thalamus compared to controls.
- Elevated T1ρ relaxation times were associated with reduced brain volumes in these subcortical regions in JOHD.
- Mean T1ρ relaxation times in these areas were directly proportional to UHDRS scores, indicating a correlation with disease severity and motor deficits.
Conclusions:
- Subcortical metabolic abnormalities, detectable by T1-Rho MRI, are present in JOHD.
- These metabolic changes are linked to brain volume reduction and clinical manifestations, including motor deficits.
- T1-Rho MRI may serve as a potential biomarker for disease progression and severity in JOHD.
Abstract:
Huntington's disease (HD) is a fatal neurodegenerative disease caused by the expansion of cytosine-adenine-guanine (CAG) repeats in the huntingtin gene. An increased CAG repeat length is associated with an earlier disease onset. About 5% of HD cases occur under the age of 21 years, which are classified as juvenile-onset Huntington's disease (JOHD). Our study aims to measure subcortical metabolic abnormalities in JOHD participants. T1-Rho (T1ρ) MRI was used to compare brain regions of 13 JOHD participants and 39 controls. Region-of-interest analyses were used to assess differences in quantitative T1ρ relaxation times. We found that the mean relaxation times in the caudate (p < 0.001), putamen (p < 0.001), globus pallidus (p < 0.001), and thalamus (p < 0.001) were increased in JOHD participants compared to controls. Furthermore, increased T1ρ relaxation times in these areas were significantly associated with lower volumes amongst participants in the JOHD group. These findings suggest metabolic abnormalities in brain regions previously shown to degenerate in JOHD. We also analyzed the relationships between mean regional T1ρ relaxation times and Universal Huntington's Disease Rating Scale (UHDRS) scores. UHDRS was used to evaluate participants' motor function, cognitive function, behavior, and functional capacity. Mean T1ρ relaxation times in the caudate (p = 0.003), putamen (p = 0.005), globus pallidus (p = 0.009), and thalamus (p = 0.015) were directly proportional to the UHDRS score. This suggests that the T1ρ relaxation time may also predict HD-related motor deficits. Our findings suggest that subcortical metabolic abnormalities drive the unique hypokinetic symptoms in JOHD.
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies IV: Magnetic Resonance Imaging

